Monday’s Top Biotech & Medical Stocks
From BioHealth Investor
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 375Boston Scientific Begging For Good News
It’s always an interesting phenomenon when a large company becomes ultra-sensitive to news, as Boston Scientific (BSX) seems to be doing these days. BSX shares are up nearly 8% this morning to $16.20 on…
Peregrine “Compares” to Avastin
Peregrine Pharmaceuticals, Inc. (PPHM-NASDAQ) just issued a press release showing "Peregrine’s Selective Anti-VEGF Antibodies Inhibited Tumor Growth By 90% In a Preclinical Cancer Model" AND "Shows Peregrine’s Selective Anti-VEGF Antibodies are as Effective as…
Vertex Options Active Ahead of Data Presentation
Vertex (VRTX-NASDAQ) is seeing quite a bit of trading today ahead of a data presentation tomorrow. This one may have been very active all on its own, but since Dendreon (DNDN-NASDAQ) made its exponential…
Someone At Merck Is Crazy
Merck’s new arthritis drug Arcoxia was rejected by an FDA panel by a vote of 20-to-1. Apparently, the drug has cardiovascular risks. The same problem with a related drug that company produced, Vioxx, has…
Thursday’s Top Biotech & Medical Stocks
by H.S. AyoubBioHealth Investor.com
Cramer Looking For the Next Dendreon
Cramer said in a video this afternoon on TheStreet.com that this Dendreon (DNDN-NASDAQ) is a classic case of short sellers not covering themselves by not buying calls with the strikes above. The street.com ran…
MedImmune Decides To Pursue a Sale
MedImmune, Inc. (MEDI-NASDAQ) announced that its board of directors has authorized management to evaluate whether third parties would have an interest in acquiring the company at a price and on terms that would represent…
Wednesday’s Top Biotech & Medical Stocks
by H.S. AyoubBioHealth Investor.com
BioWatch Alert: eXegenics Jumps 10% on Strong Volume, No News!
by H.S. AyoubBioHealthInvestor.com
Genentech Cruised Past Estimates
Genetech (DNA-NYSE) posted earnings: $0.74 EPS and revenues were $2.843 Billion; expectations were $0.67 EPS & R$2.74 Billion. The stock is still at the lower end of its recent trading range of 2007. Avastin…
Cell Genesys Slips New Holders a Mickey
Cell Genesys, Inc. (CEGE-NASDAQ) has done what many small biotechs do that are in need of cash: sell shares in a private placement "PIPE" after a sharp stock run-up. It has entered into definitive…
Dendreon Downgraded, Sort Of…..
Dendreon (DNDN-NASDAQ) is trading down more than 4% at $21.25 in early trading after JMP Securities downgraded the shares. DNDN closed down 6% at $22.15 yesterday . The “official” rating was cut from a…
Tuesday’s Top Biotech & Medical Stocks
by H.S. AyoubBioHealth Investor.com
Amgen CFO Walks Out; Any More Execs Leaving?
Amgen (AMGN-NASDAQ) is naming a new CFO. Robert Bradway is replacing Richard Nanula, who is leaving to pursue other opportunities. Bradway came to Amgen in 2006 and prior to that he was with Morgan…